Latest News Releases
Alexandria, Va. — Sen. Richard Shelby (R-Ala.) and Representative Rosa DeLauro (D-Conn.) were recognized last night by the American Society of Clinical Oncology, the American Association for Cancer Research, the Association of American Cancer Institutes, and Friends of Cancer Research for their outstanding commitment to cancer research and leadership in funding for biomedical science.
ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today highlighted seven studies in a presscast from among more than 4,500 abstracts publicly posted online at abstract.asco.org in advance of ASCO’s 49th Annual Meeting.
ALEXANDRIA, Va.— A new ASCO survey of U.S. oncology practices shows the automatic two percent budget cut to Medicare chemotherapy drug reimbursement under sequestration is already having a significant impact on care for people with cancer just one month after the federal funding reduction went into effect.
ALEXANDRIA, Va. — Robert S. Miller, MD, FACP, a medical oncologist and recognized authority in breast cancer, survivorship care, and consumer health informatics, has been appointed Editor-in-Chief of ASCO’s patient information website, Cancer.Net. He will assume this role at the 2013 ASCO Annual Meeting in Chicago on June 1, and succeeds Diane Blum, MSW, Chief Executive Officer for the Lymphoma Research Foundation (LRF), who served as Editor-in-Chief for 10 years.
ALEXANDRIA, Va. — This year is likely to bring significant policy and practice challenges to the medical community with possible dramatic changes in how Medicare reimburses physicians for treating patients.
Today, out of concern for public safety, Congress provided the Federal Aviation Administration enhanced flexibility in application of sequestration related cuts, including reversal of furlough requirements imposed on air traffic controllers.
A study analyzing the impact of the Delaware Cancer Consortium, the state’s cancer control program, reports a 41 percent reduction in colorectal mortality rates for African Americans.
This afternoon, President Obama released his proposed budget for fiscal year 2014. Among several cost-cutting measures designed to preserve Medicare solvency is a proposal to reduce reimbursement for life-sustaining cancer drugs. Currently, reimbursement to physicians for “Part B” drugs is based on the average sales price plus a 6 percent payment for services needed to administer chemotherapy in physicians’ offices, where most cancer patients receive their care. The President has proposed to reduce the 6 percent service payment to 3 percent. (The budget proposal appears to apply cuts primarily to physicians, but also mentions rebates that will be required by manufacturers.)
ALEXANDRIA, Va. - Summary of a study being published online April 8, 2013 in the Journal of Clinical Oncology, reports that adding cetuximab (Erbitux) to chemotherapy enabled previously inoperable patients to undergo surgery, tripling the rates of successful surgery for liver metastasis.